Wu‐tong Ju

588 total citations
27 papers, 358 citations indexed

About

Wu‐tong Ju is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Wu‐tong Ju has authored 27 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Surgery and 10 papers in Otorhinolaryngology. Recurrent topics in Wu‐tong Ju's work include Head and Neck Cancer Studies (10 papers), Salivary Gland Tumors Diagnosis and Treatment (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Wu‐tong Ju is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Salivary Gland Tumors Diagnosis and Treatment (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Wu‐tong Ju collaborates with scholars based in China, United States and United Kingdom. Wu‐tong Ju's co-authors include Lai‐ping Zhong, Tongchao Zhao, Dongwang Zhu, Siyuan Liang, Zhihang Zhou, Minjun Dong, Jiang Li, Ying Liu, Lizhen Wang and Guopei Zhu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Clinical Nutrition.

In The Last Decade

Wu‐tong Ju

27 papers receiving 355 citations

Peers

Wu‐tong Ju

ONCOL

OTORH

SURGE

Zi‐Zhan Li China

Juntao Huang China

Elham Alsahafi Saudi Arabia

Anxun Wang China

Runzhi Deng China

Chad E. Galer United States

Yasunao Kogashiwa Japan

Yuichi Ohnishi Japan

E Vairaktaris Greece

Hisako Fujihara Japan

Zi‐Zhan Li China

Wu‐tong Ju

104 ×0.7

ONCOL

116 ×0.9

65 ×0.7

OTORH

63 ×0.8

SURGE

60 ×1.1

Citations per year, relative to Wu‐tong Ju Wu‐tong Ju (= 1×) peers Zi‐Zhan Li

Countries citing papers authored by Wu‐tong Ju

Since Specialization

Citations

This map shows the geographic impact of Wu‐tong Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu‐tong Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu‐tong Ju more than expected).

Fields of papers citing papers by Wu‐tong Ju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wu‐tong Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu‐tong Ju. The network helps show where Wu‐tong Ju may publish in the future.

Co-authorship network of co-authors of Wu‐tong Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Wu‐tong Ju. A scholar is included among the top collaborators of Wu‐tong Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wu‐tong Ju. Wu‐tong Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Zhisong, Mingjun Zhang, Shusuan Jiang, et al.. (2024). BGB-A317-212: A multicenter, open-label, phase II study to evaluate the efficacy and safety of tislelizumab in combination with lenvatinib in patients with selected solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2610–2610. 1 indexed citations

Zhong, Lai‐ping, Zhihang Zhou, Yi Lu, et al.. (2024). Associations of ctDNA clearance and pathological response after neoadjuvant treatment in patients with locally advanced oral cancer.. Journal of Clinical Oncology. 42(16_suppl). 6043–6043. 1 indexed citations

Ju, Wu‐tong, Ying Liu, Jingjing Sun, et al.. (2023). Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? A retrospective cohort study. International Journal of Surgery. 109(4). 879–886. 2 indexed citations

Huang, Yingying, Jingjing Sun, Dongwang Zhu, et al.. (2023). Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial). International Journal of Surgery. 109(8). 2220–2227. 39 indexed citations

Ju, Wu‐tong, Ronghui Xia, Dongwang Zhu, et al.. (2022). A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma. Nature Communications. 13(1). 78 indexed citations

Huang, Yingying, Jun Li, Dongwang Zhu, et al.. (2022). Neoadjuvant Immunochemotherapy for Locally Advanced Resectable Oral Squamous Cell Carcinoma: A Prospective Single-Arm Trial. SSRN Electronic Journal. 1 indexed citations

Zhong, Lai‐ping, Yingying Huang, Jun Li, et al.. (2022). Neoadjuvant trial with toripalimab, albumin paclitaxel, and cisplatin on pathological response in locally advanced resectable oral squamous cell carcinoma (Illuminate Trial).. Journal of Clinical Oncology. 40(16_suppl). e18067–e18067. 3 indexed citations

Sun, Wenwen, Tongchao Zhao, Timothy Aladelusi, et al.. (2021). Decreased Annexin A1 expression enhances sensitivity to docetaxel, cisplatin and 5‐fluorouracil combination induction chemotherapy in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 50(8). 795–802. 3 indexed citations

Liang, Siyuan, Tongchao Zhao, Zhihang Zhou, et al.. (2021). Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo. Translational Oncology. 14(6). 101074–101074. 18 indexed citations

10.

Zhou, Zhi-Hang, Siyuan Liang, Tongchao Zhao, et al.. (2021). Overcoming chemotherapy resistance using pH-sensitive hollow MnO2 nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma. Journal of Nanobiotechnology. 19(1). 157–157. 47 indexed citations

11.

Zhao, Tongchao, Siyuan Liang, Wu‐tong Ju, et al.. (2020). High‐risk lymph node ratio predicts worse prognosis in patients with locally advanced oral cancer. Journal of Oral Pathology and Medicine. 49(8). 787–795. 14 indexed citations

12.

Zhao, Tongchao, Siyuan Liang, Wu‐tong Ju, et al.. (2019). Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma. Clinical Nutrition. 39(9). 2751–2758. 8 indexed citations

13.

Ju, Wu‐tong, Tongchao Zhao, Ying Liu, et al.. (2019). Clinical and pathologic analysis of myopericytoma in the oral and maxillofacial region. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 128(4). 393–399. 8 indexed citations

14.

Ju, Wu‐tong, Tongchao Zhao, Ying Liu, et al.. (2019). Computed tomographic features of adenoid cystic carcinoma in the palate. Cancer Imaging. 19(1). 3–3. 7 indexed citations

15.

Ma, Jie, Yong Fu, Ying Liu, et al.. (2018). Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma. BMC Cancer. 18(1). 758–758. 22 indexed citations

16.

Tang, Xiao, Yongjie Hu, Wu‐tong Ju, et al.. (2018). Elevated growth differentiating factor 15 expression predicts long‑term benefit of docetaxel, cisplatin and 5‑fluorouracil induction chemotherapy in patients with oral cancer. Oncology Letters. 15(5). 8118–8124. 9 indexed citations

17.

Liu, Ying, Wenwen Sun, Wu‐tong Ju, et al.. (2018). Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI–TOF–MS Analysis. PROTEOMICS - CLINICAL APPLICATIONS. 12(5). e1700180–e1700180. 10 indexed citations

18.

Ma, Hailong, Shufang Jin, Wu‐tong Ju, et al.. (2017). Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 36(1). 109–109. 31 indexed citations

19.

Ju, Wu‐tong, Yong Fu, Ying Liu, et al.. (2017). Clinical and pathologic analyses of tuberculosis in the oral cavity: report of 11 cases. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 125(1). 44–51. 13 indexed citations

20.

Lu, Liyan, et al.. (2012). Cutaneous Rosai-Dorfman Disease Recurrence in Infraorbital Region. Journal of Craniofacial Surgery. 23(5). e509–e510. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact